If you’re like many Americans, the rising cost of prescription drugs may be costing you your health. In particular, seniors living on a fixed income with no insurance are finding it difficult to pay for necessary prescriptions out-of-pocket, and as a result, may be failing to receive the treatment they need to stay healthy. Often, the struggle can buy th-pvp strain on seniors’ finances. But why are prescription drug prices so high, especially when most people who require medication are usually not in a financial position that allows them to afford the full price tag? The real reasons are more complicated than what you might suspect, but one thing’s for certain – drug prices have been skyrocketing.
The reason that is most often touted (by the drug companies, of course) for the high price of drugs is research and development (R&D) costs. The drug companies contest that the only way to pay for the development of new life-saving drugs – that will improve the lives of millions of Americans – is through profits from current drug sales. The high prices, they say, are merely a reflection of the spending that is necessary for the creation of newer, better drugs. But is this the truth? Are drug companies using a large percentage of current prescription drug sales to fund R&D? If so, are the new drugs under development truly going to improve the health of the people who need them most? Sadly, this doesn’t appear to be the case.
In reality, drug companies spend more on advertising, lobbying and political contributions than they do on research and development. Most of the money you pay for prescription medication ends up in the pockets of marketers and politicians, so that you can be convinced that you need the buy 4 aco dmt vendor drugs that are under development. In addition, research and development tends to focus on more “marketable” types of drugs that the drug companies can sell to the largest amounts of people. How many times have you seen advertisements for a drug that can help alleviate such serious medical conditions as social anxiety disorder and seasonal allergies?
Developing new allergy or anxiety drugs, however, does not require massive amounts of money, as these drugs have already been developed. Neither does rehashing previously developed drugs to be marketed for a new ailment. Usually the newer drugs under “development” aren’t new at all. So even the money that is spent on R&D, it can be argued, is an unnecessary expense driven by the market more than by the country’s medical needs. Unfortunately, this means that most large drug companies tend to neglect the development of life-saving drugs for more serious conditions, as the numbers are not there to rake in high profits.